Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$5.06 - $26.46 $3.16 Million - $16.5 Million
-624,860 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$19.99 - $33.23 $11.9 Million - $19.8 Million
595,616 Added 2036.71%
624,860 $15.2 Million
Q4 2021

Feb 14, 2022

BUY
$29.39 - $46.86 $271,681 - $433,173
9,244 Added 46.22%
29,244 $942,000
Q3 2021

Nov 15, 2021

BUY
$35.91 - $50.5 $718,199 - $1.01 Million
20,000 New
20,000 $894,000

Others Institutions Holding CCCC

About C4 Therapeutics, Inc.


  • Ticker CCCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,913,800
  • Market Cap $211M
  • Description
  • C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...
More about CCCC
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.